-transparent.png){kind=logo}
Large granular lymphocyte (LGL) leukemia is a rare disease characterized by clonal expansion of LGL associated with chronic neutropenia, multiple auto-antibodies, and occasionally polyarthritis. We studied cell surface antigen expression and functional activity of leukemic LGL from ten such patients. Using two-color flow cytometric analysis, we found that leukemic LGL from all ten patients expressed the CD3 and HNK-1 markers, while cells from only four patients expressed IgG Fc receptors (FcR). The LGL leukemic cells had little or no NK activity (defined as MHC-nonrestricted cytotoxicity against K562 target cells); however, NK activity could be induced in leukemic LGL by in vitro treatment with as little as 0.05 microgram/mL of anti-CD3 monoclonal antibody. Cell sorting experiments demonstrated that NK activity was induced in CD3+ leukemic LGL (either CD3+, HNK-1+ or CD3+, FcR+) with anti-CD3 monoclonal antibody but not in normal CD3+, FcR- T cells. Treatment with purified interleukin 2 (IL 2) also caused direct activation of some CD3+ leukemic LGL. Despite induction with anti-CD3 MAb or IL 2, activated leukemic LGL did not proliferate or express high density IL 2 receptors detectable by cell sorter analysis. Treatment with alpha interferon had minimal effect on NK activity of LGL leukemic cells. These results suggest that leukemic LGL may provide a useful model for examining the signals required for LGL maturation and activation.
T P Loughran, and
K E Draves, and
G Starkebaum, and
P Kidd, and
E A Clark
March 1982,
Journal of immunology (Baltimore, Md. : 1950),
T P Loughran, and
K E Draves, and
G Starkebaum, and
P Kidd, and
E A Clark
February 1990,
Blood,
T P Loughran, and
K E Draves, and
G Starkebaum, and
P Kidd, and
E A Clark
December 1990,
Cellular immunology,
T P Loughran, and
K E Draves, and
G Starkebaum, and
P Kidd, and
E A Clark
June 1995,
Blood,
T P Loughran, and
K E Draves, and
G Starkebaum, and
P Kidd, and
E A Clark
October 1994,
Blood,
T P Loughran, and
K E Draves, and
G Starkebaum, and
P Kidd, and
E A Clark
March 1988,
Blood,
T P Loughran, and
K E Draves, and
G Starkebaum, and
P Kidd, and
E A Clark
December 2021,
Annales de biologie clinique,
T P Loughran, and
K E Draves, and
G Starkebaum, and
P Kidd, and
E A Clark
September 2019,
Best practice & research. Clinical haematology,
T P Loughran, and
K E Draves, and
G Starkebaum, and
P Kidd, and
E A Clark
January 1990,
American journal of hematology,
T P Loughran, and
K E Draves, and
G Starkebaum, and
P Kidd, and
E A Clark
April 1988,
Blood,
